Table 2.
Quality assessment of each article included in the systematic review.
| References | Study design | Selection | Comparability | Outcome | Total stars | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Representati-veness of the sample | Sample size justification | Exclusion of other relevant diseases | Ascertainment of exposure (C9orf72) | Control for confounding factors | Assessment of outcome (HLD diagnosis) | Statistical test | ||||
| Hensman Moss et al. (2014a) | Cross-sectional | + | ++ | ++ | + | 6/10 | ||||
| Kostic et al. (2014) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Koutsis et al. (2015) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Mariani et al. (2016) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Martins et al. (2018a) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Baine et al. (2018) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Ida et al. (2018) | Cross-sectional | + | + | ++ | ++ | + | 7/10 | |||
| Kaur et al. (2020) | Cross-sectional | + | ++ | + | 4/10 | |||||
| References | Study design | Selection | Comparability | Exposure | Total stars | |||||
| Case definition (HLD diagnosis) | Representativeness of the cases to target population | Selection of community-based controls | Definition of controls | Control for confounding factors | Ascertainment of exposure (C9orf72) | Same method used for cases and controls | All cases and controls were assessed for exposure | |||
| Rikos et al. (2020) | Case-control | + | + | + | + | + | + | + | 7/9 | |
| Fedotova et al. (2016) | Case-control | + | + | + | + | + | + | 6/9 | ||
HLD, Huntington-Like Disorder.